oxytetracycline--anhydrous and Weight-Loss

A field trial was performed under commercial feedlot conditions in western Canada to compare the efficacy of a new formulation of long-acting oxytetracycline (LA 30) to a standard long-acting oxytetracycline formulation (LA 20) and florfenicol (FLOR) for the treatment of undifferentiated fever (UF) in calves that received metaphylactic tilmicosin upon arrival at the feed-lot. Seven hundred and ninety-seven recently weaned, auction market derived, crossbred, beef calves suffering from UF were allocated to 1 of 3 experimental groups as follows: LA 30, which received intramuscular long-acting oxytetracycline (300 mg/mL formulation) at the rate of 30 mg/kg body weight (BW) at the time of allocation; LA 20, which received intramuscular long-acting oxytetracycline (200 mg/mL formulation) at the rate of 20 mg/kg BW at the time of allocation; or FLOR, which received intramuscular florfenicol administered at the rate of 20 mg/kg BW at the time of allocation and again 48 hours later. Two hundred and sixty-six animals were allocated to the LA 30 group, 265 animals were allocated to the LA 20 group, and 266 animals were allocated to the FLOR group. The relative efficacy of the LA 30 group, as compared with the LA 20 and FLOR groups, was assessed by comparing relapse, chronicity, wastage, and mortality rates. The overall mortality (RR = 0.50) rate in the LA 30 group was significantly (P < 0.05) lower than in the LA 20 group. However, the overall chronicity (RR = 2.56) and overall wastage (RR = 6.97) rates of the LA 30 group were significantly (P < 0.05) higher than in the LA 20 group. There were no significant (P > or = 0.05) differences in UF relapse rates or cause specific mortality rates between the LA 30 and LA 20 groups. In the economic analysis, there was an advantage of $28.59 CDN per animal in the LA 30 group compared with the LA 20 group. The overall chronicity (RR = 2.25) and overall wastage (RR = 2.80) rates of the LA 30 group were significantly (P < 0.05) higher than the FLOR group. There were no significant (P > or = 0.05) differences in UF relapse rates, overall mortality rates, or cause specific mortality rates between the LA 30 and FLOR groups. In the economic analysis, there was an advantage of $12.90 CDN per animal in the LA 30 group compared with the FLOR group. In summary, the results of this study indicate that it is more cost-effective to use a new formulation of long-acting oxytetracycline (300 mg/mL formulation administered at a rate of 30 mg/k

Topics: Animals; Anti-Bacterial Agents; Canada; Cattle; Cattle Diseases; Chronic Disease; Cost-Benefit Analysis; Fever; Injections, Intramuscular; Oxytetracycline; Random Allocation; Recurrence; Thiamphenicol; Treatment Outcome; Weight Loss

An experiment was conducted to determine the effects of 1) long-acting oxytetracycline injection at market arrival, 2) feed or water access at the auction market and 3) receiving diet management on commingled feeder pig performance. A total of 288 commingled feeder pigs transported over 1,000 km after market management treatments were used in two trials. Pigs given access to feed and water (FW) at the market weighed more (P less than .001) following marketing and transport than pigs given water only (W). Pigs given neither feed nor water (N) were intermediate in arrival weight (19.7, 18.7 and 18.9 kg). There was no effect (P greater than .1) of feed and water offering at the market on final weight (96.6, 95.9 and 96.6 kg), overall average daily gain (.70, .69 and .70 kg/d), overall gain/feed (.31, .31, .32) or percentage death loss (1.0, 2.1 and 4.2%). Injection of long-acting oxytetracycline upon arrival at auction market had no effect (P greater than .1) on pig weight following marketing and transport (19.0 vs 19.2 kg), final weight (96.1 vs 97.0 kg), percentage death loss (3.4 vs 1.4%) or percentage of pigs treated (3.4 vs 4.9%). Compared to providing ad libitum access to feed, restricting feed intake by floor feeding for the first 7 d post-arrival reduced (P less than .01) rate of gain for the first 9 d (-.04 vs. .08 kg/d), but overall there was no effect (P greater than .1) on daily gain (.70 vs .69 kg/d) or gain/feed (.31 vs .31).

Topics: Animal Feed; Animals; Diet; Food Deprivation; Oxytetracycline; Random Allocation; Swine; Water Deprivation; Weight Gain; Weight Loss